Understanding statistical hypothesis testing

BMJ (Online)

Volumn 348, Issue , 2014, Pages

  Sedgwick, Philip ^a  

^a ST GEORGE'S UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

COTININE; PLACEBO; VARENICLINE; BENZAZEPINE DERIVATIVE; NICOTINE GUM; NICOTINIC AGENT; QUINOXALINE DERIVATIVE;

COUNSELING; DRUG EFFICACY; EQUIPOISE; FOLLOW UP; HUMAN; NOTE; NULL HYPOTHESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKELESS TOBACCO; SMOKING CESSATION; STATISTICAL ANALYSIS; ADOLESCENT; ADULT; PROCEDURES; STATISTICS; YOUNG ADULT;

ADOLESCENT; ADULT; BENZAZEPINES; DATA INTERPRETATION, STATISTICAL; HUMANS; NICOTINIC AGONISTS; QUINOXALINES; SMOKING CESSATION; STATISTICS AS TOPIC; TOBACCO USE CESSATION PRODUCTS; YOUNG ADULT;

EID: 84901698915     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.g3557     Document Type: Note

References (3)

1. Fagerström K, Gilljam H, Metcalfe M, Tonstad S, Messig M. Stopping smokeless tobacco with varenicline: randomised double blind placebo controlled trial. BMJ 2010;341:c6549.
2. Sedgwick P. Clinical significance versus statistical significance. BMJ 2014;348:g2130.
3. Sedgwick P. The importance of statistical power. BMJ 2013;347:f6282.